Jean-Paul Vilaine

USPTO Granted Patents = 28 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 174(Granted Patents)

Location History:

Le Plessis Robinson, FR (1988 - 1989)
Chatenay, FR (1993)
Chatenay Malabry, FR (1991 - 2017)

Company Filing History:

Les Laboratoires Servier

Les Laboratories Servier

patents

Years Active: 1988-2017

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9809553 - Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them (2017-11-07),

2. 8076325 - 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them (2011-12-13),

3. 6908922 - Linear cyclic ureas (2005-06-21),

4. 6903103 - Linear cyclic ureas (2005-06-07),

5. 6780868 - Linear cyclic ureas (2004-08-24),

6. 6696469 - Cyclobutenedione compounds (2004-02-24),

7. 6566364 - Linear or cyclic ureas (2003-05-20),

8. 6323217 - Piperidine-4 sulphonamide compounds (2001-11-27),

9. 5734077 - Substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters (1998-03-31),

10. 5627205 - Substituted phenoxyisobutyric acids and esters (1997-05-06),

11. 5569647 - Angiopeptin cyclopeptide compounds (1996-10-29),

12. 5565457 - Substituted sulfonamides (1996-10-15),

13. 5512595 - Substituted phenoxyisobutyric acids and esters (1996-04-30),

14. 5457103 - 3',5'-di-tert.-butyl-4'-hydroxy flavones (1995-10-10),

15. 5389644 - 1,4-dihydropyridine compounds (1995-02-14),

Title: Jean-Paul Vilaine: Innovator in Medicinal Chemistry

Introduction

Jean-Paul Vilaine, based in Chatenay Malabry, France, is a prominent inventor in the field of medicinal chemistry. With an impressive portfolio of 28 patents, he has made significant contributions to the development of pharmaceutical compounds that address various health conditions.

Latest Patents

Among his latest innovations, Vilaine has developed isoquinoline compounds, along with procedures for their synthesis and formulations containing these substances. These compounds are particularly relevant for creating medicinal products that aid in treating or preventing pathologies linked to the activation of the RhoA/ROCK pathway and the phosphorylation of the myosin light chain. Additionally, he has worked on 1,2,4,5-tetrahydro-3H-benzazepine compounds, which also include a detailed process for their preparation and pharmaceutical compositions useful in treating a variety of medical conditions.

Career Highlights

Vilaine’s career is marked by his association with notable companies such as Adir Et Compagnie and Les Laboratoires Servier. His work within these organizations has been pivotal in advancing research and product development in the field of pharmaceuticals.

Collaborations

Throughout his career, Vilaine has collaborated with distinguished professionals, including Jean-Louis Peglion and Nicole Villeneuve. These partnerships have allowed for the exchange of innovative ideas and the advancement of research projects aimed at creating effective medicinal solutions.

Conclusion

Jean-Paul Vilaine stands out as a key figure in medicinal chemistry, evidenced by his extensive patent portfolio and collaborations. His ongoing contributions to the pharmaceutical industry continue to pave the way for new treatments and advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.